Featured Stories
How Math Can Potentially Reduce Unnecessary Breast Biopsies
MDDIonline.com – May 11, 2018
Optoacoustic Imaging Enhances Breast Cancer Diagnosis
ClinicalOncology.com – May 04, 2018
Seno touts study on downgrading breast mass risk
AuntMinnie.com – May 04, 2018
New imaging technique helps radiologists downgrade benign breast masses
Radiology Business – April 18, 2018
Opto-Acoustic Imaging Shines a Light on Breast Cancer
Novus Light – February 12, 2018
Imagio® Combines Optoacoustics with Ultrasound for Breast Cancer Diagnosis
Coherent News – January 8, 2018
New Data Supports Diagnostic Capability of Imagio® Opto-Acoustic Breast Imaging System
MedLatest – December 11, 2017
The Prognostic Potential of Opto-Acoustic Imaging in Patients with Breast Cancer
ConsultQD.clevelandclinic.org – December 8, 2017
Opto-acoustic imaging (OA), an exciting new means of illuminating vascular properties of tumors and surrounding tissues, promises to be a clinical staple for evaluation and management of patients with breast cancer.
Seno Medical’s Imagio® Combines Optoacoustics with Ultrasound to Diagnose Breast Cancer
medGadget – December 5, 2017
Experimental Imaging Device Spots BrCA
MedPage Today – November 30, 2017
Opto-acoustic ultrasound improves specificity compared with gray scale ultrasound
Optoacoustic Device Aids Breast Lesion Assessment
AuntMinnie.com – November 29, 2017
Imagio® Opto-Acoustic Breast Imaging System Reduces False Positive Breast Exams
MedLatest – November 28, 2017
Seno Medical Presents Results of MAESTRO Study at EUSOBI
AuntMinnieEurope.com – September 27, 2016
Breast imaging developer Seno Medical Instruments announced interim results from its MAESTRO study at last week’s European Society of Breast Imaging (EUSOBI) meeting in Paris. The results from the study demonstrate the potential…
New Interim Results Support Imagio® Opto-Acoustic (OA) Breast Imaging System’s Potential to Reduce Negative Biopsies
HealthCareBusiness Daily News (via PR Newswire) – Sepetmber 24, 2014
SAN ANTONIO, Sept. 24, 2016 /PRNewswire/ — Seno Medical Instruments, Inc. (Seno Medical), the company pioneering the development of opto-acoustic technology as a tool to improve the process of diagnosing breast cancer…
Seno Medical Reports Positive Interim Data from Maestro Study of Breast Imaging System
Medical Device Network Market & Customer Insight – September 26, 2016
US-based medical imaging company Seno Medical has reported positive interim results from its MAESTRO study of Imagio opto-acoustic (OA) a breast imaging system used to detect breast cancer…
New Interim Results Support Imagio Opto-Acoustic (OA) Breast Imaging System’s Potential to Reduce Negative Biopsies
BioSpace (via PR Newswire) – September 26, 2016
Seno Medical Instruments, Inc. (Seno Medical), the company pioneering the development of opto-acoustic technology as a tool to improve the process of diagnosing breast cancer, announced today…
Print This Page